Font Size:
a
A
A
Keyword [Programmed cell death ligand 1(PD-L1)]
Result: 1 - 9 | Page: 1 of 1
1.
Potential Predictive Value Of TP53 And KRAS Mutation To PD-1 Blockade Immunotherapy In Lung Adenocarcinoma
2.
Clinical Characteristics And Programmed Cell Death Ligand-1 Expression In Lung Adenocarcinoma In Situ And Minimally Invasive Adenocarcinoma Of Lung
3.
The Role Of Aurora-A Inhibitors In Remodelling Breast Cancer Tumor Microenvironment
4.
Study Of Relation Between PD-L1 Expression And EGFR-TKIs Resistance Mechanism In Non-small Cell Lung Cancer
5.
Expression Of PD-1 And PD-L1 In Ovarian Tumors A Nd Its Clinical Significance
6.
Clinicopathologic Significance And Prognostic Value Of Programmed Cell Death Ligand 1(PD-L1)in Patients With Hepatocellular Carcinoma:a Meta-analysis
7.
Construction Of Sentinel Lymph Node Metastasis Prediction Model(PUMCH-SLN) For Breast Cancer And The Mechanism Of P53/AKT/JAK-STAT Regulatory Network Regulating Immune Escape Of Breast Cancer Cells
8.
Tumor Immune Microenvironment Subtyping And Its Multi-omics Molecular Features In The Evaluation Of The Efficacy And Prognosis Of Anti-PD-1/PD-L1 Immunotherapy
9.
The Expression Of Tumor Mutation Board And Programmed Cell Death Ligand 1 In Esophageal Squamous Cell Carcinoma And Its Clinical Significance
<<First
<Prev Next>
Last>>
Jump to
